By 340B Matters It’s 365 days and counting since the Department of Health and Human Services referred scofflaw drug companies to the Office of Inspector General for assessment of civil monetary penalties for violating the 340B Drug Discount Program. It’s an anniversary that none of America’s...
By 340B Matters The 340B Drug Discount Program celebrates its 30th birthday this year. Over the past three decades, it has helped safety-net hospitals and clinics across the country care for underserved populations – just as Congress intended. These nonprofit healthcare organizations are on the front line....
By 340B Matters Big Pharma has been trying to maim or kill the 340B Drug Discount Program for years and hasn’t succeeded. That’s because it has enjoyed enormous bi-partisan support from successive presidential administrations as well as hundreds of members of the U.S. House and Senate. “Every...
By 340B Matters Recently, 25 state attorneys general signed onto two friend-of-the-court briefs excoriating the drug industry for illegally denying discounts to hospitals and clinics in the federal 340B Drug Discount Program. We applaud these leaders – and particularly Connecticut Attorney General William Tong, for leading...
By 340B Matters So far, seven of the world’s largest drug manufacturers have been referred to the Department of Health and Human Services Office of Inspector General for blatantly breaking the law regarding the 340B Drug Discount Program. The situation has cost affected hospitals and clinics $6...
By 340B Matters As lawmakers return to their districts and states for recess, we want to applaud a bipartisan group of congressional leaders that have been staunch champions for the 340B Drug Discount Program. These individuals have stood up for their local safety-net hospitals and clinics...
By 340B Matters Big Pharma has stolen $6 billion from safety-net hospitals and clinics during the past two years. The effect has been huge, leading to service cutbacks to low-income patients amid a roiling pandemic. Fourteen gigantic drug companies have shamelessly robbed the 340B Drug Discount Program....
By 340B Matters Dear Secretary Becerra, As America’s safety-net healthcare providers struggle with the Omicron crush, thirteen huge drug companies have illegally cut or announced plans to end access to the vital 340B Drug Discount Program. That means hospitals and clinics have billions of dollars less to...
By 340B Matters Despite Big Pharma’s efforts to eviscerate the 340B Drug Discount Program, recent federal court decisions have made it clear that manufacturers are acting illegally. Eli Lilly, along with eight other huge drug makers, have unilaterally limited required drug discounts to safety-net health care...
By 340B Matters The drug industry already has some of the highest profit margins of any sector and they're getting higher for Eli Lilly. U.S. revenues increased by a whopping 26% last quarter - that’s a big jump for a company that posted $6 billion in...
